Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of KRN125 for chemotherapy-induced neutropenia in malignant lymphoma
jRCT2080220851Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pegfilgrastim in chemotherapy-induced neutropenia (CIN), Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL), sponsored by Kyowa Kirin.
02
Drugs
pegfilgrastim
03
Conditions
chemotherapy-induced neutropenia (CIN)Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on jRCT2080220851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220851.